NLNG Unveils GenScan AI, Prize-Winning Tool for Faster MRI

Nigeria LNG Ltd. (NLNG) has formally presented GenScan Artificial Intelligence (AI), the winning work of The Nigeria Prize for Science and Innovation (NPSI) 2026, to Nigerians, describing it as a technology that could speed up Magnetic Resonance Imaging (MRI) and widen access to diagnostic services.

 

The company's Manager, Corporate Communications and Public Affairs, Mrs Anne-Marie Palmer-Ikuku, disclosed this in a statement issued on Monday in Port Harcourt. The public presentation took place in Abuja the same day.

 

Developed by Mary-Brenda Akoda, GenScan AI applies artificial intelligence to shorten MRI scan times while maintaining or improving image quality, Palmer-Ikuku said.

 

She explained that the tool's C-MORE algorithm reconstructs MRI images using a one-step framework.

 

"The algorithm has the potential to reduce MRI scan acquisition times by up to 90 per cent without requiring new MRI hardware," she said.

 

According to Palmer-Ikuku, shorter scans could allow healthcare providers to attend to more patients and cut waiting periods. The technology, she added, could also improve the use of existing MRI equipment and support more efficient diagnostic services.

 

She noted that the NPSI, sponsored by NLNG, recognises excellence in scientific research and promotes innovations that address practical challenges.

 

The statement quoted Mrs Sophia Horsfall, NLNG's General Manager, External Relations and Sustainable Development, as saying that accurate diagnosis was essential to effective treatment.

 

Horsfall said diagnostic imaging provided the evidence that enabled medical teams to identify conditions and make informed decisions about patient care.

 

"Our interest goes beyond recognising an outstanding idea. We want to see scientific research make a practical difference in people's lives," she said.

 

She said GenScan AI offered prospects for faster medical imaging and better use of existing equipment, adding that the presentation was an opportunity to discuss the steps needed to turn the technology's potential into practical application.

 

Prof. Barth Nnaji of the NPSI Advisory Board said the winning work stood out for its scientific strength and its potential to meet a practical healthcare need.

 

He identified engagement with clinicians and other stakeholders as the next step in assessing how the technology could be used safely and effectively.

 

Akoda emerged winner of the 2026 prize from a record 237 entries, following an independent evaluation by a panel of judges chaired by Dr Omobola Johnson and endorsement by the Advisory Board.

 

She is the first woman to win the prize as an individual recipient and will receive the 100,000-dollar (N135.6 million) prize at the Grand Award Night on Oct. 9.